The significant miss in both EPS and sales compared to analyst estimates is likely to negatively impact investor sentiment and the stock price of Journey Medical in the short term. The miss in EPS by a large margin is particularly concerning, indicating operational challenges. However, the year-over-year increase in sales suggests some positive business momentum, which might mitigate the negative impact slightly.